Streptozotocin and Alloxan in Experimental Diabetes. Comparison of the Two Models in Rats.
- 1 January 2000
- journal article
- Published by Japan Society of Histochemistry & Cytochemistry in ACTA HISTOCHEMICA ET CYTOCHEMICA
- Vol. 33 (3) , 201-208
- https://doi.org/10.1267/ahc.33.201
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Protective Mechanism of Glucose Against Alloxan-Induced Pancreatic β-Cell DamageBiochemical and Biophysical Research Communications, 1995
- Involvement of Spontaneous Nitric Oxide Production in the Diabetogenic Action of StreptozotocinPharmacology, 1995
- INHIBIN GENE EXPRESSION IN THE HUMAN CORPUS LUTEUMJournal of Endocrinology, 1987
- Protective Role of Superoxide Dismutase against Diabetogenic DrugsJournal of Clinical Investigation, 1982
- Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic isletsNature, 1981
- Protection against streptozotocin-induced diabetes by superoxide dismutaseDiabetologia, 1980
- Diabetogenic action of streptozotocin: relationship of dose to metabolic responseJournal of Clinical Investigation, 1969
- COMPARISON OF METABOLIC ABNORMALITIES IN DIABETES MELLITUS INDUCED BY STREPTOZOTOCIN OR BY ALLOXANThe Lancet, 1968
- Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*Journal of Clinical Investigation, 1967
- NOTICE TO CORRESPONDENTS.The Lancet, 1824